{"result": {"id": "chatcmpl-52", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **United States** faces significant health challenges related to e-cigarette or vaping product use-associated lung injury (EVALI) and chronic lung injury (CLI), with an estimated two million people affected by CLI.  Despite these challenges, the country boasts a 5-year survival rate of approximately 7% for glioblastoma (GBM). The **United States** is also a leader in research related to angiogenesis and flap-related procedures, publishing the most studies and conducting the majority of this research within its borders. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743241124, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 108, "prompt_tokens": 275, "total_tokens": 383, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"UNITED STATES\"\nDescription List: [\"The **United States** has been grappling with the health challenges posed by EVALI (e-cigarette or vaping product use-associated lung injury), resulting in a significant number of cases.  Furthermore, the country is facing a large-scale outbreak of Chronic Lung Injury (CLI), affecting an estimated two million people.  Despite these challenges, the **United States** also has a 5-year survival rate for GBM (Glioblastoma) of approximately 7%. \\n\", \"The **United States** is a country that publishes the most studies on angiogenesis and flap-related research, and is also the location where most of these studies are conducted. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_b9247f5a1ce2211bd323546f7ceacf641b96a9a316df6b22815baa4d1e623644_v2"}